Cholamandalam Investment and Finance Company Ltd (CHOLAFIN):企業の財務・戦略的SWOT分析

◆英語タイトル:Cholamandalam Investment and Finance Company Ltd (CHOLAFIN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0783
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥17,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥51,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Cholamandalam Investment and Finance Company Ltd (CHOLAFIN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cholamandalam Investment and Finance Company Ltd (CIFCL), a subsidiary of Murugappa Group, is a diversified non-banking finance company, which offers lending and other financial solutions. Its offerings comprise of lending solutions for vehicle, including commercial vehicles, tractors, cars and MUVs and construction vehicles and equipment; loans against property; home for remodeling of existing homes, purchase of plots and ready homes, and balance transfer of existing home loans ; SME loans; rural and agriculture; and corporate financing. It also provides investment products, such as mutual funds, stock, derivatives, bonds, and exchange-traded funds; online broking; DEMAT solutions and freight data solutions. CIFCL is headquartered in Chennai, Tamil Nadu, in India.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Cholamandalam Investment and Finance Company Ltd – Key Facts
Cholamandalam Investment and Finance Company Ltd – Key Employees
Cholamandalam Investment and Finance Company Ltd – Key Employee Biographies
Cholamandalam Investment and Finance Company Ltd – Major Products and Services
Cholamandalam Investment and Finance Company Ltd – History
Cholamandalam Investment and Finance Company Ltd – Company Statement
Cholamandalam Investment and Finance Company Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Cholamandalam Investment and Finance Company Ltd – Business Description
Business Segment: Home Equity
Overview
Performance
Key Stats
Business Segment: Others
Overview
Performance
Key Stats
Business Segment: Unallocable
Overview
Performance
Key Stats
Business Segment: Vehicle Finance
Overview
Performance
Key Stats
Cholamandalam Investment and Finance Company Ltd – SWOT Analysis
SWOT Analysis – Overview
Cholamandalam Investment and Finance Company Ltd – Strengths
Cholamandalam Investment and Finance Company Ltd – Weaknesses
Cholamandalam Investment and Finance Company Ltd – Opportunities
Cholamandalam Investment and Finance Company Ltd – Threats
Cholamandalam Investment and Finance Company Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Cholamandalam Investment and Finance Company Ltd, Key Facts
Cholamandalam Investment and Finance Company Ltd, Key Employees
Cholamandalam Investment and Finance Company Ltd, Key Employee Biographies
Cholamandalam Investment and Finance Company Ltd, Major Products and Services
Cholamandalam Investment and Finance Company Ltd, History
Cholamandalam Investment and Finance Company Ltd, Subsidiaries
Cholamandalam Investment and Finance Company Ltd, Key Competitors
Cholamandalam Investment and Finance Company Ltd, Ratios based on current share price
Cholamandalam Investment and Finance Company Ltd, Annual Ratios
Cholamandalam Investment and Finance Company Ltd, Annual Ratios (Cont...1)
Cholamandalam Investment and Finance Company Ltd, Annual Ratios (Cont...2)
Cholamandalam Investment and Finance Company Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Cholamandalam Investment and Finance Company Ltd, Performance Chart (2015 - 2019)
Cholamandalam Investment and Finance Company Ltd, Ratio Charts

★海外企業調査レポート[Cholamandalam Investment and Finance Company Ltd (CHOLAFIN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Champions Oncology Inc (CSBR):製薬・医療:M&Aディール及び事業提携情報
    Summary Champions Oncology Inc (Champions), formerly Champions Biotechnology Inc, is a developer of advanced technology solutions and services to personalize the development and use of oncology drugs. The company’s technology platform is an approach based upon the implantation of primary human tumor …
  • Grupo Televisa, S.A.B. (TLEVISACPO):企業の財務・戦略的SWOT分析
    Grupo Televisa, S.A.B. (TLEVISACPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Chubu Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    Chubu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Chubu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • MSCI Inc. (MSCI):企業の財務・戦略的SWOT分析
    MSCI Inc. (MSCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • China General Plastics Corp (1305):企業の財務・戦略的SWOT分析
    Summary China General Plastics Corp (CGPC), a subsidiary of USI Group is a chemical company that manufactures PVC resins. The company's products include poly vinyl chloride resins, raw materials, vinyl films, films and sheet products, construction products, leather products, and house ware products. …
  • Daily Mail & General Trust plc (DMGT):企業の財務・戦略的SWOT分析
    Daily Mail & General Trust plc (DMGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Munchener Ruckversicherungs-Gesellschaft AG (Munich Re):企業のM&A・事業提携・投資動向
    Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes b …
  • Alvogen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Alvogen Inc (Alvogen) develops, manufactures and markets biosimilar products, generic pharmaceuticals and OTC products. The company’s product portfolio comprises generic medications in various therapeutic areas that include oncology, cardiology, respiratory, neurology and gastroenterology. A …
  • Seiko Epson Corp (6724):企業の財務・戦略的SWOT分析
    Seiko Epson Corp (6724) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • DURECT Corp (DRRX)-医療機器分野:企業M&A・提携分析
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • Outotec Oyj:企業のM&A・事業提携・投資動向
    Outotec Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Outotec Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Zavante Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Zavante Therapeutics Inc (Zavante), formerly SG Pharmaceuticals Inc is a developer of novel therapies for the treatment of infectious diseases. The company offers drugs for the treatment of diseases that affect patients in the hospital setting. Its lead product candidate ZOLYD, is an investi …
  • Bilfinger Tebodin B.V.:企業の戦略的SWOT分析
    Bilfinger Tebodin B.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sequa Petroleum NV (MLSEQ):企業の財務・戦略的SWOT分析
    Summary Sequa Petroleum NV (Sequa Petroleum) is an oil and gas company. It develops, acquires, monetises, produces and finances oil and natural gas assets. The company holds assets in Europe, Central and West Africa and the Middle East. Sequa Petroleum has a large development and producing area in N …
  • Wireless Group Limited:企業の戦略的SWOT分析
    Wireless Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • AmerisourceBergen Corporation:企業の戦略・SWOT・財務分析
    AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report Summary AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Indiana Municipal Power Agency-エネルギー分野:企業M&A・提携分析
    Summary Indiana Municipal Power Agency (IMPA) is a not-for-profit wholesale power provider supplying power to cities and communities across Indiana and Ohio. The agency was formed by its member utilities which enable them to share power resources and provide electricity economically to their custome …
  • California Cryobank-製薬・医療分野:企業M&A・提携分析
    Summary California Cryobank (CCB) is a healthcare service provider that offers reproductive, stem cell and donor selection services. The center offers services such as donor semen, pricing, donor information subscriptions, graduate donors, donor information, consultation services, genetic services, …
  • Brown-Forman Corporation:企業の戦略・SWOT・財務情報
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ASKA Pharmaceutical Co Ltd (4514):製薬・医療:M&Aディール及び事業提携情報
    Summary ASKA Pharmaceutical Co Ltd (ASKA) is a pharmaceutical company that offers quasi-drugs, foods, medical devices and veterinary medicines. The company imports and export pharmaceuticals and medical devices. Its activities comprise production, drug information, and research and development servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆